Skip to main content

High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial.

Publication ,  Conference
Richards, JM; Bedikian, A; Gonzalez, R; Atkins, MB; Whitman, E; Lutzky, J; Morse, MA; Amatruda, T; Galanis, E; Thompson, J
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

720S / 720S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Richards, J. M., Bedikian, A., Gonzalez, R., Atkins, M. B., Whitman, E., Lutzky, J., … Thompson, J. (2005). High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 720S-720S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Richards, J. M., A. Bedikian, R. Gonzalez, M. B. Atkins, E. Whitman, J. Lutzky, M. A. Morse, T. Amatruda, E. Galanis, and J. Thompson. “High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial.” In JOURNAL OF CLINICAL ONCOLOGY, 23:720S-720S. AMER SOC CLINICAL ONCOLOGY, 2005.
Richards JM, Bedikian A, Gonzalez R, Atkins MB, Whitman E, Lutzky J, et al. High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 720S-720S.
Richards, J. M., et al. “High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial.JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 720S-720S.
Richards JM, Bedikian A, Gonzalez R, Atkins MB, Whitman E, Lutzky J, Morse MA, Amatruda T, Galanis E, Thompson J. High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 720S-720S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

720S / 720S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences